29 3月 2024 by admin in UncategorizedComments 礼邦医药在研创新药物 AP303 获得美国食品药品监督管理局(FDA)孤儿药 资格认定, 用于治疗常染色体显性多囊肾病(ADPKD)
26 3月 2024 by admin in UncategorizedComments Avenzo Therapeutics Announces $150 Million Oversubscribed Financing To Advance Emerging Oncology Pipeline
06 3月 2024 by admin in UncategorizedComments Zenas BioPharma Appoints Patricia Allen to its Board of Directors
